Pertuzumab (also called 2C4, trade name Perjeta) is a monoclonal antibody used in combination with trastuzumab and docetaxel for the treatment of metastatic HER2-positive breast cancer; it also used in the same combination as a neoadjuvant in early HER2-positive breast cancer.
IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.
For procurement cost of PERJETA (pertuzumab) brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the ALUNBRIG (pertuzumab) tablets cost price in India.
The order for PERJETA (pertuzumab) will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
PERJETA® (pertuzumab) Injection, for intravenous use. Initial U.S. Approval: 2012
Generic Name: pertuzumab
420 mg/14 mL single-use vial.
IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand PERJETA (pertuzumab) on prescription and Import License in Patient's Name only.
For overseas patients, PERJETA (pertuzumab) can be made available in Send your enquiry to find PERJETA (pertuzumab) in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
For PERJETA (pertuzumab) Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details
Addition of Perjeta to Standard Care Improves Survival in HER2-Positive Early Breast Cancer For More Details
Treatment with anti-cancer drug T-DM1 after pertuzumab is 'good option For More Details